by MH Team | Oct 9, 2023 | White Blood Cells
TL;DR Hodgkin Lymphoma is a heterogeneous group of disorders caused by malignant lymphocytes that accumulate in lymph nodes presenting as lymphadenopathy. Hodgkin lymphoma is differentiated from non-Hodgkin lymphoma by presence of Reed-Sternberg (RS) cells and a...
by MH Team | Oct 9, 2023 | White Blood Cells
TL;DR Chronic myeloid leukemia (CML) is a slower progressing clonal disorder of the hematopoietic stem cells where untreated patients progress to blast crisis stage after 3 – 5 years. It has a peak incidence at 40 – 60 years old. Signs and symptoms ▾...
by MH Team | Oct 9, 2023 | White Blood Cells
TL;DR Chronic lymphocytic leukemia (CLL) is a slow progressing cancer due to overgrowth and accumulation of small incompetent mature-looking B-lymphocytes in the blood, bone marrow and lymphoid tissues. Small lymphocytic leukemia is a different clinical manifestation...
by MH Team | Oct 9, 2023 | White Blood Cells
Introduction Acute leukemia, a devastating form of blood cancer, arises from the uncontrolled growth and proliferation of immature blood cells, known as blasts. These abnormal cells crowd out the healthy blood cells, disrupting the body’s ability to produce...
by MH Team | Oct 9, 2023 | Lab Protocols, Red Blood Cells
Introduction Prussian blue (Perls’) reaction is a method for staining non-heme iron in normoblasts (siderocytes), macrophages (hemosiderin), and other cells containing particulate iron. The granules are formed of a water-insoluble complex of ferric iron, lipid,...
Recent Comments